This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Mar 25;1(8065):659-60.

doi: 10.1016/s0140-6736(78)91161-3.

Cholinesterase inhibition in treatment of Alzheimer's dementia

Comfort

PMID: 76190
DOI: 10.1016/s0140-6736(78)91161-3

Cholinesterase inhibition in treatment of Alzheimer's dementia

Comfort. Lancet. 1978.

. 1978 Mar 25;1(8065):659-60.

doi: 10.1016/s0140-6736(78)91161-3.

Author

Comfort

PMID: 76190
DOI: 10.1016/s0140-6736(78)91161-3

No abstract available

PubMed Disclaimer

Similar articles

[Aspects of the report of the IQWiG (Institute for Quality and Cost Effectiveness in Public Health) " Cholinesterase inhibitors in Alzheimer's dementia"].
Gogol M, Lüttje D, Werner H. Gogol M, et al. Z Gerontol Geriatr. 2007 Jun;40(3):192-4. doi: 10.1007/s00391-007-0458-y. Z Gerontol Geriatr. 2007. PMID: 17565437 German. No abstract available.
Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?
Liberini P, Valerio A, Memo M, Spano PF. Liberini P, et al. Trends Pharmacol Sci. 1996 Apr;17(4):155-60. doi: 10.1016/0165-6147(96)81592-6. Trends Pharmacol Sci. 1996. PMID: 8984743 Review.
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman D. Masterman D. Clin Geriatr Med. 2004 Feb;20(1):59-68. doi: 10.1016/j.cger.2003.11.002. Clin Geriatr Med. 2004. PMID: 15062487 No abstract available.
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
Gustavsson A, Van Der Putt R, Jönsson L, McShane R. Gustavsson A, et al. Int J Geriatr Psychiatry. 2009 Oct;24(10):1072-8. doi: 10.1002/gps.2223. Int J Geriatr Psychiatry. 2009. PMID: 19639600
Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?
Small DH. Small DH. Expert Opin Emerg Drugs. 2005 Nov;10(4):817-25. doi: 10.1517/14728214.10.4.817. Expert Opin Emerg Drugs. 2005. PMID: 16262564 Review.

See all similar articles

Cited by

Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment.
Jang YJ, Kang SJ, Park HS, Lee DH, Kim JH, Kim JE, Kim DI, Chung CH, Yoon JK, Bhang SH. Jang YJ, et al. J Nanobiotechnology. 2025 Feb 10;23(1):99. doi: 10.1186/s12951-025-03109-3. J Nanobiotechnology. 2025. PMID: 39930497 Free PMC article. Review.
Four decades of neurodegenerative disease research: how far we have come!
Young AB. Young AB. J Neurosci. 2009 Oct 14;29(41):12722-8. doi: 10.1523/JNEUROSCI.3767-09.2009. J Neurosci. 2009. PMID: 19828782 Free PMC article. No abstract available.
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Perry EK, et al. Br Med J. 1978 Nov 25;2(6150):1457-9. doi: 10.1136/bmj.2.6150.1457. Br Med J. 1978. PMID: 719462 Free PMC article.
Cholinesterases and the fine line between poison and remedy.
Pope CN, Brimijoin S. Pope CN, et al. Biochem Pharmacol. 2018 Jul;153:205-216. doi: 10.1016/j.bcp.2018.01.044. Epub 2018 Jan 31. Biochem Pharmacol. 2018. PMID: 29409903 Free PMC article. Review.
A Debatable Top Ten Papers in Geriatric Medicine List.
Hogan DB. Hogan DB. Can Geriatr J. 2020 Sep 1;23(3):228-234. doi: 10.5770/cgj.23.440. eCollection 2020 Sep. Can Geriatr J. 2020. PMID: 32904746 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database